Navamedic ASA (OSL:NAVA)
Norway · Delayed Price · Currency is NOK 16.35
0.00 (0.00%)
Aug 4, 2026, 11:12 AM CET
Navamedic ASA Market Cap
Navamedic ASA has a market cap or net worth of 392.1 million as of August 4, 2026. Its market cap has decreased by -5.54% in one year.
Market Cap
392.10M
Enterprise Value
529.73M
Revenue
571.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.35
ChartMarket Cap Chart
Since March 31, 2006, Navamedic ASA's market cap has increased from 111.70M to 392.10M, an increase of 251.04%. That is a compound annual growth rate of 6.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 392.10M | -31.30% |
| Dec 30, 2025 | 570.76M | 25.74% |
| Dec 30, 2024 | 453.93M | -28.72% |
| Dec 29, 2023 | 636.85M | 5.92% |
| Dec 30, 2022 | 601.25M | 8.19% |
| Dec 30, 2021 | 555.75M | 90.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.19B |
| Circio Holding ASA | 2.11B |
| Thor Medical ASA | 2.04B |
| Nordhealth AS | 1.86B |
| Omda AS | 779.29M |
| Zelluna ASA | 664.75M |
| Lytix Biopharma ASA | 647.50M |
| Gentian Diagnostics ASA | 613.71M |